Abstract Background Generation of induced pluripotent stem cells (iPSCs) from human peripheral blood provides a convenient and low-invasive way to obtain patient-specific iPSCs. The episomal vector is one of the best approaches for reprogramming somatic cells to pluripotent status because of its simplicity and affordability. However, the efficiency of episomal vector reprogramming of adult peripheral blood cells is relatively low compared with cord blood and bone marrow cells. Methods In the present study, integration-free human iPSCs derived from peripheral blood were established via episomal technology. We optimized mononuclear cell isolation and cultivation, episomal vector promoters, and a combination of transcriptional factors to impro...
Bone marrow-derived mesenchymal stem cells (BM-MSCs) possess excellent therapeutic potential for the...
Human induced pluripotent stem cells (hiPSCs) can self-renew indefinitely and have the potential to ...
The most pressing issue in generating induced pluripotent stem cells (iPSCs) in clinical practice is...
SummaryWe previously reported the generation of integration-free induced pluripotent stem cells from...
SummaryWe previously reported the generation of integration-free induced pluripotent stem cells from...
The ability to efficiently generate integration-free induced pluripotent stem cells (iPSCs) from the...
Generation of induced pluripotent stem cells (iPSCs) by defined factors (OCT4, SOX2, C-MYC, and KLF4...
AbstractBreakthroughs in cell fate conversion have made it possible to generate large quantities of ...
We describe a method to transform blood lymphocytes into human-induced pluripotent stem cells by del...
The methodology to create induced pluripotent stem cells (iPSCs) affords the opportunity to generate...
# The Author(s) 2015. This article is published with open access at Springerlink.com Abstract Human ...
Genetic reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) could offer r...
AbstractHuman neural stem cells (NSCs) hold great promise for research and therapy in neural disease...
Isolated peripheral blood mononuclear cells (PBMCs) from a healthy female were successfully transfor...
AbstractBackgroundHuman induced pluripotent stem cells (iPSCs) morphologically and functionally rese...
Bone marrow-derived mesenchymal stem cells (BM-MSCs) possess excellent therapeutic potential for the...
Human induced pluripotent stem cells (hiPSCs) can self-renew indefinitely and have the potential to ...
The most pressing issue in generating induced pluripotent stem cells (iPSCs) in clinical practice is...
SummaryWe previously reported the generation of integration-free induced pluripotent stem cells from...
SummaryWe previously reported the generation of integration-free induced pluripotent stem cells from...
The ability to efficiently generate integration-free induced pluripotent stem cells (iPSCs) from the...
Generation of induced pluripotent stem cells (iPSCs) by defined factors (OCT4, SOX2, C-MYC, and KLF4...
AbstractBreakthroughs in cell fate conversion have made it possible to generate large quantities of ...
We describe a method to transform blood lymphocytes into human-induced pluripotent stem cells by del...
The methodology to create induced pluripotent stem cells (iPSCs) affords the opportunity to generate...
# The Author(s) 2015. This article is published with open access at Springerlink.com Abstract Human ...
Genetic reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) could offer r...
AbstractHuman neural stem cells (NSCs) hold great promise for research and therapy in neural disease...
Isolated peripheral blood mononuclear cells (PBMCs) from a healthy female were successfully transfor...
AbstractBackgroundHuman induced pluripotent stem cells (iPSCs) morphologically and functionally rese...
Bone marrow-derived mesenchymal stem cells (BM-MSCs) possess excellent therapeutic potential for the...
Human induced pluripotent stem cells (hiPSCs) can self-renew indefinitely and have the potential to ...
The most pressing issue in generating induced pluripotent stem cells (iPSCs) in clinical practice is...